Unity Biotechnology, Inc. (UNBX)
OTCMKTS · Delayed Price · Currency is USD
0.0550
-0.0487 (-46.96%)
At close: Aug 1, 2025
Unity Biotechnology Employees
Unity Biotechnology had 16 employees as of December 31, 2024. The number of employees decreased by 3 or -15.79% compared to the previous year.
Employees
16
Change (1Y)
-3
Growth (1Y)
-15.79%
Revenue / Employee
n/a
Profits / Employee
-$1,718,875
Market Cap
1.78M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 16 | -3 | -15.79% |
Dec 31, 2023 | 19 | -13 | -40.63% |
Dec 31, 2022 | 32 | -33 | -50.77% |
Dec 31, 2021 | 65 | 4 | 6.56% |
Dec 31, 2020 | 61 | -37 | -37.76% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
Endo, Inc. | 3,116 |
Tian'an Technology Group | 8 |
Elite Pharmaceuticals | 68 |
Glass House Brands | 374 |
CytoDyn | 13 |
Northwest Biotherapeutics | 25 |
American Oncology Network | 1,914 |
Silence Therapeutics | 116 |
Unity Biotechnology News
- 3 months ago - UNITY Biotechnology to Present at the ARVO 2025 Annual Meeting - GlobeNewsWire
- 3 months ago - UNITY Biotechnology, Inc. Reports First Quarter 2025 Financial Results and Business Updates - GlobeNewsWire
- 4 months ago - Unity Biotechnology Unveils Mixed Data From Study For Diabetes-Related Blindness, Stock Falls - Benzinga
- 4 months ago - UNITY Biotechnology Announces Topline Results from the ASPIRE Phase 2b Study in Diabetic Macular Edema - GlobeNewsWire
- 4 months ago - UNITY Biotechnology to Host Virtual Investor Event to Discuss 24- and 36-Week Data from the Phase 2b ASPIRE Study of UBX1325 in Patients with Diabetic Macular Edema (DME) on March 24, 2025 - GlobeNewsWire
- 5 months ago - UNITY Biotechnology, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Business Updates - GlobeNewsWire
- 7 months ago - UNITY Biotechnology Reports Granting of New Employment Inducement Award - GlobeNewsWire
- 7 months ago - UNITY Biotechnology Announces Appointment of Federico Grossi, M.D., Ph.D., as Chief Medical Officer - GlobeNewsWire